Terms: = Lymphoma AND MYC, c-Myc, 4609, ENSG00000136997
4082 results:
1. Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing.
Lahey KC; Varsanyi C; Wang Z; Aquib A; Gadiyar V; Rodrigues AA; Pulica R; Desind S; Davra V; Calianese DC; Liu D; Cho JH; Kotenko SV; De Lorenzo MS; Birge RB
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673989
[TBL] [Abstract] [Full Text] [Related]
2. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
[TBL] [Abstract] [Full Text] [Related]
3. Circular ZDHHC11 supports Burkitt lymphoma growth independent of its miR-150 binding capacity.
Liu Y; Zhao X; Seitz A; Hooijsma AA; Ravanbakhsh R; Sheveleva S; de Jong D; Koerts J; Dzikiewicz-Krawczyk A; van den Berg A; Ziel-Swier LJYM; Kluiver J
Sci Rep; 2024 Apr; 14(1):8730. PubMed ID: 38627588
[TBL] [Abstract] [Full Text] [Related]
4. Latent Epstein-Barr virus infection collaborates with myc over-expression in normal human B cells to induce Burkitt-like lymphomas in mice.
Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
[TBL] [Abstract] [Full Text] [Related]
5. Novel PIKfyve/Tubulin Dual-target Inhibitor as a Promising Therapeutic Strategy for B-cell Acute Lymphoblastic Leukemia.
Lu Z; Lai Q; Li ZF; Zhong MY; Jiang YL; Feng LY; Zha J; Yao JW; Li Y; Deng XM; Xu B
Curr Med Sci; 2024 Apr; 44(2):298-308. PubMed ID: 38619682
[TBL] [Abstract] [Full Text] [Related]
6. Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells.
Liu Y; Zhang S; Tan Y
Hematology; 2024 Dec; 29(1):2337307. PubMed ID: 38573223
[No Abstract] [Full Text] [Related]
7. Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma.
Hoang NM; Liu Y; Bates PD; Heaton AR; Lopez AF; Liu P; Zhu F; Chen R; Kondapelli A; Zhang X; Selberg PE; Ngo VN; Skala MC; Capitini CM; Rui L
Cell Rep Med; 2024 Apr; 5(4):101484. PubMed ID: 38554704
[TBL] [Abstract] [Full Text] [Related]
8. The Genetic Profile of Large B-Cell lymphomas Presenting in the Ocular Adnexa.
Vest SD; Eriksen PRG; de Groot FA; de Groen RAL; Kleij AHR; Kirkegaard MK; Kamper P; Rasmussen PK; von Buchwald C; de Nully Brown P; Kiilgaard JF; Vermaat JSP; Heegaard S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542066
[TBL] [Abstract] [Full Text] [Related]
9. Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::BCL3 identified by G-banding and fluorescence in situ hybridization.
Ohno H; Maekawa F; Hayashida M; Nakagawa M; Fukutsuka K; Matsumura M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S; Tanaka Y; Haga H
J Clin Exp Hematop; 2024; 64(1):21-31. PubMed ID: 38538317
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of the MALT1-LPCAT3 axis protects cartilage degeneration and osteoarthritis.
Kondreddy V; Banerjee R; Devi BLAP; Muralidharan K; Piramanayagam S
Cell Commun Signal; 2024 Mar; 22(1):189. PubMed ID: 38519981
[TBL] [Abstract] [Full Text] [Related]
11. STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.
Prutsch N; He S; Berezovskaya A; Durbin AD; Dharia NV; Maher KA; Matthews JD; Hare L; Turner SD; Stegmaier K; Kenner L; Merkel O; Look AT; Abraham BJ; Zimmerman MW
Cell Rep Med; 2024 Mar; 5(3):101472. PubMed ID: 38508140
[TBL] [Abstract] [Full Text] [Related]
12. Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses.
Shichijo T; Yasunaga JI; Sato K; Nosaka K; Toyoda K; Watanabe M; Zhang W; Koyanagi Y; Murphy EL; Bruhn RL; Koh KR; Akari H; Ikeda T; Harris RS; Green PL; Matsuoka M
Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2309925121. PubMed ID: 38502701
[TBL] [Abstract] [Full Text] [Related]
13. Translation efficiency driven by CNOT3 subunit of the CCR4-NOT complex promotes leukemogenesis.
Ghashghaei M; Liu Y; Ettles J; Bombaci G; Ramkumar N; Liu Z; Escano L; Miko SS; Kim Y; Waldron JA; Do K; MacPherson K; Yuen KA; Taibi T; Yue M; Arsalan A; Jin Z; Edin G; Karsan A; Morin GB; Kuchenbauer F; Perna F; Bushell M; Vu LP
Nat Commun; 2024 Mar; 15(1):2340. PubMed ID: 38491013
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2
Ichikawa T; Suekane A; Nakahata S; Iha H; Shimoda K; Murakami T; Morishita K
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474089
[TBL] [Abstract] [Full Text] [Related]
15. SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions.
Deng Q; Lakra P; Gou P; Yang H; Meydan C; Teater M; Chin C; Zhang W; Dinh T; Hussein U; Li X; Rojas E; Liu W; Reville PK; Kizhakeyil A; Barisic D; Parsons S; Wilson A; Henderson J; Scull B; Gurumurthy C; Vega F; Chadburn A; Cuglievan B; El-Mallawany NK; Allen C; Mason C; Melnick A; Green MR
Cancer Cell; 2024 Apr; 42(4):605-622.e11. PubMed ID: 38458188
[TBL] [Abstract] [Full Text] [Related]
16. ERG and c-myc regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia.
Behrens K; Brajanovski N; Xu Z; Viney EM; DiRago L; Hediyeh-Zadeh S; Davis MJ; Pearson RB; Sanij E; Alexander WS; Ng AP
Sci Adv; 2024 Mar; 10(10):eadj8803. PubMed ID: 38457494
[TBL] [Abstract] [Full Text] [Related]
17. Comparison of genomic alterations in Epstein-Barr virus-positive and Epstein-Barr virus-negative diffuse large B-cell lymphoma.
Liu F; Tian S; Liu Q; Deng Y; He Q; Shi Q; Chen G; Xu X; Yuan J; Nakamura S; Karube K; Wang Z
Cancer Med; 2024 Feb; 13(4):e6995. PubMed ID: 38457199
[TBL] [Abstract] [Full Text] [Related]
18. Renin-Angiotensin System Inhibitors Suppress the Growth of Leukemia Cells.
Itoh M; Sasaki S; Tohda S
Anticancer Res; 2024 Mar; 44(3):1183-1192. PubMed ID: 38423665
[TBL] [Abstract] [Full Text] [Related]
19. Effect of Ferroptosis Inducers and Inhibitors on Cell Proliferation in Acute Leukemia.
Kumada H; Itoh M; Tohda S
Anticancer Res; 2024 Mar; 44(3):1003-1010. PubMed ID: 38423654
[TBL] [Abstract] [Full Text] [Related]
20. Plasmablastic lymphoma: current knowledge and future directions.
Li JW; Peng HL; Zhou XY; Wang JJ
Front Immunol; 2024; 15():1354604. PubMed ID: 38415257
[TBL] [Abstract] [Full Text] [Related]
[Next]
